- Home
- FOLD vs ARLP Comparison
FOLD vs ARLP Comparison
Compare FOLD & ARLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- ARLP
- Stock Information
- Founded
- FOLD 2002
- ARLP 1971
- Country
- FOLD United States
- ARLP United States
- Employees
- FOLD N/A
- ARLP N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- ARLP Coal Mining
- Sector
- FOLD Health Care
- ARLP Energy
- Exchange
- FOLD Nasdaq
- ARLP Nasdaq
- Market Cap
- FOLD 2.9B
- ARLP 3.4B
- IPO Year
- FOLD 2007
- ARLP 1999
- Fundamental
- Price
- FOLD $6.83
- ARLP $27.17
- Analyst Decision
- FOLD Strong Buy
- ARLP Strong Buy
- Analyst Count
- FOLD 9
- ARLP 1
- Target Price
- FOLD $17.00
- ARLP $29.00
- AVG Volume (30 Days)
- FOLD 3.9M
- ARLP 569.4K
- Earning Date
- FOLD 05-08-2025
- ARLP 04-28-2025
- Dividend Yield
- FOLD N/A
- ARLP 10.31%
- EPS Growth
- FOLD N/A
- ARLP N/A
- EPS
- FOLD N/A
- ARLP 2.77
- Revenue
- FOLD $528,294,999.00
- ARLP $2,448,708,000.00
- Revenue This Year
- FOLD $21.83
- ARLP N/A
- Revenue Next Year
- FOLD $22.16
- ARLP $3.83
- P/E Ratio
- FOLD N/A
- ARLP $9.80
- Revenue Growth
- FOLD 32.29
- ARLP N/A
- 52 Week Low
- FOLD $6.20
- ARLP $20.91
- 52 Week High
- FOLD $12.65
- ARLP $30.56
- Technical
- Relative Strength Index (RSI)
- FOLD 32.01
- ARLP 58.42
- Support Level
- FOLD $6.20
- ARLP $25.76
- Resistance Level
- FOLD $6.95
- ARLP $27.79
- Average True Range (ATR)
- FOLD 0.43
- ARLP 1.28
- MACD
- FOLD -0.04
- ARLP 0.09
- Stochastic Oscillator
- FOLD 29.86
- ARLP 88.71
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About ARLP Alliance Resource Partners L.P. Common Units representing Limited Partners Interests
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments Illinois Basin, Appalachia, Oil & Gas Royalties and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties has included coal mineral reserves and resources owned or leased by Alliance Resource Properties.